Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1-4 using conserved and serotype-specific 3' noncoding sequences.
Houng HS, Chung-Ming Chen R, Vaughn DW, Kanesa-thasan N. Houng HS, et al. J Virol Methods. 2001 Jun;95(1-2):19-32. doi: 10.1016/s0166-0934(01)00280-4. J Virol Methods. 2001. PMID: 11377710
Evaluation of dengue virus strains for human challenge studies.
Mammen MP, Lyons A, Innis BL, Sun W, McKinney D, Chung RC, Eckels KH, Putnak R, Kanesa-thasan N, Scherer JM, Statler J, Asher LV, Thomas SJ, Vaughn DW. Mammen MP, et al. Among authors: kanesa thasan n. Vaccine. 2014 Mar 14;32(13):1488-94. doi: 10.1016/j.vaccine.2013.12.040. Epub 2014 Jan 24. Vaccine. 2014. PMID: 24468542 Clinical Trial.
Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers.
Kanesa-thasan N, Sun W, Kim-Ahn G, Van Albert S, Putnak JR, King A, Raengsakulsrach B, Christ-Schmidt H, Gilson K, Zahradnik JM, Vaughn DW, Innis BL, Saluzzo JF, Hoke CH Jr. Kanesa-thasan N, et al. Vaccine. 2001 Apr 30;19(23-24):3179-88. doi: 10.1016/s0264-410x(01)00020-2. Vaccine. 2001. PMID: 11312014 Clinical Trial.
Molecular and epidemiologic analysis of dengue virus isolates from Somalia.
Kanesa-thasan N, Chang GJ, Smoak BL, Magill A, Burrous MJ, Hoke CH Jr. Kanesa-thasan N, et al. Emerg Infect Dis. 1998 Apr-Jun;4(2):299-303. doi: 10.3201/eid0402.980220. Emerg Infect Dis. 1998. PMID: 9621203 Free PMC article.
Atypical antibody responses in dengue vaccine recipients.
Kanesa-Thasan N, Sun W, Ludwig GV, Rossi C, Putnak JR, Mangiafico JA, Innis BL, Edelman R. Kanesa-Thasan N, et al. Am J Trop Med Hyg. 2003 Dec;69(6 Suppl):32-8. doi: 10.4269/ajtmh.2003.69.32. Am J Trop Med Hyg. 2003. PMID: 14740953
Short report: absence of protective neutralizng antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines.
Kanesa-Thasan N, Putnak JR, Mangiafico JA, Saluzzo JE, Ludwig GV. Kanesa-Thasan N, et al. Am J Trop Med Hyg. 2002 Feb;66(2):115-6. doi: 10.4269/ajtmh.2002.66.115. Am J Trop Med Hyg. 2002. PMID: 12135278
Dengue fever in US military personnel in Haiti.
Trofa AF, DeFraites RF, Smoak BL, Kanesa-thasan N, King AD, Burrous JM, MacArthy PO, Rossi C, Hoke CH Jr. Trofa AF, et al. JAMA. 1997 May 21;277(19):1546-8. JAMA. 1997. PMID: 9153369
Early indicators of exposure to biological threat agents using host gene profiles in peripheral blood mononuclear cells.
Das R, Hammamieh R, Neill R, Ludwig GV, Eker S, Lincoln P, Ramamoorthy P, Dhokalia A, Mani S, Mendis C, Cummings C, Kearney B, Royaee A, Huang XZ, Paranavitana C, Smith L, Peel S, Kanesa-Thasan N, Hoover D, Lindler LE, Yang D, Henchal E, Jett M. Das R, et al. BMC Infect Dis. 2008 Jul 30;8:104. doi: 10.1186/1471-2334-8-104. BMC Infect Dis. 2008. PMID: 18667072 Free PMC article.
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults.
Sun W, Cunningham D, Wasserman SS, Perry J, Putnak JR, Eckels KH, Vaughn DW, Thomas SJ, Kanesa-Thasan N, Innis BL, Edelman R. Sun W, et al. Hum Vaccin. 2009 Jan-Feb;5(1):33-40. doi: 10.4161/hv.5.1.6348. Epub 2009 Jan 27. Hum Vaccin. 2009. PMID: 18670195 Clinical Trial.
44 results
Jump to page
Feedback